MedKoo Cat#: 128952 | Name: SKL1223
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SKL1223 is an inhibitor of thioredoxin-interacting protein (TXNIP).

Chemical Structure

SKL1223
SKL1223
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 128952

Name: SKL1223

CAS#: N/A

Chemical Formula: C19H15N3O2

Exact Mass: 317.1164

Molecular Weight: 317.35

Elemental Analysis: C, 71.91; H, 4.76; N, 13.24; O, 10.08

Price and Availability

Size Price Availability Quantity
1mg USD 350.00 2 Weeks
5mg USD 650.00 2 Weeks
10mg USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
SKL1223; SKL 1223; SKL-1223
IUPAC/Chemical Name
N-(furan-2-ylmethyl)-4-(3-phenyl-1,2,4-oxadiazol-5-yl)aniline
InChi Key
PWITXLYJAFNARC-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H15N3O2/c1-2-5-14(6-3-1)18-21-19(24-22-18)15-8-10-16(11-9-15)20-13-17-7-4-12-23-17/h1-12,20H,13H2
SMILES Code
C1(NCC2=CC=CO2)=CC=C(C3=NC(C4=CC=CC=C4)=NO3)C=C1
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 317.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Wang, X., Luo, Z., Han, J., et al. Orally available small molecule regulates TXNIP expression and glucagon action for the treatment of diabetes. Research Square (2024).